Male Hypogonadism market

Male Hypogonadism Market - Global Outlook and Forecast 2022-2028

  • 10 March 2022
  • Life Sciences
  • 61 Pages
  • Report code : PMR-6930625

  • 4.7 (158)

Male Hypogonadism Market

COMPANIES COVERED

Astrazeneca Plc.
Merck & Co. Inc.
Laboratories Genevrier
Allergan Plc.
Endo International Plc.
Ferring
AbbVie Inc.
Eli Lilly and Company Ltd.
Finox Biotech
Teva Pharmaceutical Industries Ltd.
Bayer AG
IBSA Institut Biochimque

Download FREE Report Sample

  Download Free sample

Male hypogonadism?is a condition in which the body doesn't produce enough of the hormone that plays a key role in?masculine?growth and development during puberty (testosterone) or enough sperm or both. You can be born with?male hypogonadism, or it can develop later in life, often from injury or infection.

Male Hypogonadism Market contains market size and forecasts of Male Hypogonadism in Global, including the following market information:

Global Male Hypogonadism Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Male Hypogonadism market was valued at 3128.6 million in 2021 and is projected to reach US$ 3691.7 million by 2028, at a CAGR of 2.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Testosterone Replacement Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Male Hypogonadism include Astrazeneca Plc., Merck & Co. Inc., Laboratories Genevrier, Allergan Plc., Endo International Plc., Ferring, AbbVie Inc., Eli Lilly and Company Ltd. and Finox Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Male Hypogonadism companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Male Hypogonadism Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Male Hypogonadism Market Segment Percentages, by Type, 2021 (%)

Testosterone Replacement Therapy

Gonadotropin-Releasing Hormones Therapy

Global Male Hypogonadism Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Male Hypogonadism Market Segment Percentages, by Application, 2021 (%)

Kallmann Syndrome

Klinefelters Syndrome

Pituitary Disorders

Others

Global Male Hypogonadism Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Male Hypogonadism Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Male Hypogonadism revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Male Hypogonadism revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Astrazeneca Plc.

Merck & Co. Inc.

Laboratories Genevrier

Allergan Plc.

Endo International Plc.

Ferring

AbbVie Inc.

Eli Lilly and Company Ltd.

Finox Biotech

Teva Pharmaceutical Industries Ltd.

Bayer AG

IBSA Institut Biochimque

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Male Hypogonadism Market

Leave This Empty: